tegafur has been researched along with Brain Diseases in 6 studies
Brain Diseases: Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM.
Excerpt | Relevance | Reference |
---|---|---|
"A 42-year-old woman with reversible splenial lesion syndrome (RESLES) and rectal adenocarcinoma presented with sudden-onset delirium after the sixth cycle of her chemotherapy drug, oral tegafur-uracil (300 mg/m/day, days 1-14, with treatment cycle repeated every 21 days)." | 7.96 | Reversible Splenial Lesion Syndrome (RESLES) After Chemotherapy of Oral Tegafur-uracil in a Female With Locally Rectal Adenocarcinoma. ( Bi, QQ; Chen, YJ; Ge, YX; Lin, YY, 2020) |
"A 42-year-old woman with reversible splenial lesion syndrome (RESLES) and rectal adenocarcinoma presented with sudden-onset delirium after the sixth cycle of her chemotherapy drug, oral tegafur-uracil (300 mg/m/day, days 1-14, with treatment cycle repeated every 21 days)." | 3.96 | Reversible Splenial Lesion Syndrome (RESLES) After Chemotherapy of Oral Tegafur-uracil in a Female With Locally Rectal Adenocarcinoma. ( Bi, QQ; Chen, YJ; Ge, YX; Lin, YY, 2020) |
"A case of reversible encephalopathy induced by tegafur: a masked compound of 5-Fluorouracil, is reported and discussed." | 1.28 | [A case of reversible encephalopathy caused by tegafur]. ( Hata, T; Kakimoto, Y; Nakagawa, M; Sano, A, 1992) |
"A case of toxic leucoencephalopathy induced by 5 FU derivatives is reported." | 1.27 | [A case of toxic leucoencephalopathy induced by 5FU derivatives]. ( Ishijima, B; Mizutani, T; Morimatsu, Y; Sato, J; Yasue, M, 1985) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (33.33) | 18.7374 |
1990's | 3 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Ge, YX | 1 |
Lin, YY | 1 |
Bi, QQ | 1 |
Chen, YJ | 1 |
Ohara, S | 1 |
Hayashi, R | 1 |
Hata, S | 1 |
Itoh, N | 1 |
Hanyu, N | 1 |
Yamamoto, K | 1 |
Suzuki, K | 1 |
Nukui, A | 1 |
Kobayashi, M | 1 |
Sugaya, Y | 1 |
Muraishi, O | 1 |
Morita, T | 1 |
Tokue, A | 1 |
Hata, T | 1 |
Sano, A | 1 |
Nakagawa, M | 1 |
Kakimoto, Y | 1 |
Ikeda, K | 1 |
Kumada, H | 1 |
Arase, Y | 1 |
Chayama, K | 1 |
Gunji, T | 1 |
Yoshiba, A | 1 |
Irimoto, M | 1 |
Yasue, M | 1 |
Ishijima, B | 1 |
Sato, J | 1 |
Mizutani, T | 1 |
Morimatsu, Y | 1 |
2 reviews available for tegafur and Brain Diseases
Article | Year |
---|---|
Leukoencephalopathy induced by chemotherapy with tegafur, a 5-fluorouracil derivative.
Topics: Antimetabolites, Antineoplastic; Brain; Brain Diseases; Fatal Outcome; Frontal Lobe; Humans; Magneti | 1998 |
[A case of pulmonary metastasis from renal cell carcinoma with complete response to interferon-alpha and tegafur/uracil (UFT) but possibly UFT-induced liver dysfunction and leukoencephalopathy-like symptoms].
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Carcinoma, Renal Cell; Chemical and | 1999 |
4 other studies available for tegafur and Brain Diseases
Article | Year |
---|---|
Reversible Splenial Lesion Syndrome (RESLES) After Chemotherapy of Oral Tegafur-uracil in a Female With Locally Rectal Adenocarcinoma.
Topics: Adenocarcinoma; Adult; Antimetabolites, Antineoplastic; Brain Diseases; Female; Humans; Rectal Neopl | 2020 |
[A case of reversible encephalopathy caused by tegafur].
Topics: Aged; Brain Diseases; Electroencephalography; Electrophysiology; Evoked Potentials, Visual; Humans; | 1992 |
[Risk factors for side effects of long-term administration of 5-fluorouracil derivatives in patients with hepatocellular carcinoma associated with liver cirrhosis--relationship with serum concentration of anti-tumor agents and side effect].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Ascites; Brain Diseases; Carcinoma, Hepatocell | 1988 |
[A case of toxic leucoencephalopathy induced by 5FU derivatives].
Topics: Antineoplastic Agents; Brain; Brain Diseases; Breast Neoplasms; Female; Fluorouracil; Humans; Middle | 1985 |